FRG2B Gene

Name FSHD region gene 2 family, member B
Description Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Mar 2025]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Recent genomic investigations across a range of chronic diseases and tumors have broadened our understanding of cancer‐associated genetic alterations (for example."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "3"}]}, {"type": "t", "text": " In a comprehensive whole‐exome sequencing study of carotid paragangliomas—a neuroendocrine tumor of the head and neck—a set of 34 genes exhibiting a high mutation rate was identified."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": " Among these, FRG2B emerged as a candidate gene potentially involved in tumor initiation and progression. Although the precise function of FRG2B is not yet fully defined, its inclusion in this mutational signature suggests a possible role in perturbing cellular pathways relevant to tumorigenesis, akin to other genes involved in transcription regulation, chromatin organization, and signaling as highlighted by studies on nuclear compartment genomics"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "and homeobox gene regulation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n \n "}, {"type": "p", "children": [{"type": "t", "text": "\n Furthermore, similar genomic analyses in other malignancies have underscored the importance of identifying driver mutations that disrupt critical pathways such as apoptosis, cellular differentiation, and metabolic regulation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "7", "end_ref": "9"}]}, {"type": "t", "text": " In this collective context, the discovery of FRG2B in carotid paragangliomas supports further functional studies to clarify its contribution to tumor cell biology and to assess its potential utility as a therapeutic target.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Hitendra S Chand, Gilbert Montano, Xuesong Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A genetic variant of p53 restricts the mucous secretory phenotype by regulating SPDEF and Bcl-2 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms6567"}], "href": "https://doi.org/10.1038/ncomms6567"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25429397"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25429397"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Danja Sarink, Helena Schock, Theron Johnson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12885-018-4887-3"}], "href": "https://doi.org/10.1186/s12885-018-4887-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30348163"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30348163"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Ian Ganly, Vladimir Makarov, Shyamprasad Deraje, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccell.2018.07.002"}], "href": "https://doi.org/10.1016/j.ccell.2018.07.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30107176"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30107176"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "A V Snezhkina, E N Lukyanova, M S Fedorova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Novel Genes Associated with the Development of Carotid Paragangliomas]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol (Mosk) (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1134/S0026898419040141"}], "href": "https://doi.org/10.1134/S0026898419040141"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31397435"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31397435"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Attila Németh, Ana Conesa, Javier Santoyo-Lopez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Initial genomics of the human nucleolus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pgen.1000889"}], "href": "https://doi.org/10.1371/journal.pgen.1000889"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20361057"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20361057"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Laurens G Wilming, Veronika Boychenko, Jennifer L Harrow "}, {"type": "b", "children": [{"type": "t", "text": "Comprehensive comparative homeobox gene annotation in human and mouse."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Database (Oxford) (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/database/bav091"}], "href": "https://doi.org/10.1093/database/bav091"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26412852"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26412852"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Melanie Ehrlich, Michelle Lacey "}, {"type": "b", "children": [{"type": "t", "text": "Deciphering transcription dysregulation in FSH muscular dystrophy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hum Genet (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/jhg.2012.74"}], "href": "https://doi.org/10.1038/jhg.2012.74"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22718021"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22718021"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Hui-Ju Kao, Shun-Long Weng, Kai-Yao Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MDD-carb: a combinatorial model for the identification of protein carbonylation sites with substrate motifs."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Syst Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12918-017-0511-4"}], "href": "https://doi.org/10.1186/s12918-017-0511-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29322938"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29322938"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Qiu-Ye Lan, Gong-Cheng Liao, Rui-Fen Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dietary patterns and primary liver cancer in Chinese adults: a case-control study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.23910"}], "href": "https://doi.org/10.18632/oncotarget.23910"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29963244"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29963244"}]}]}]}
Proteins FRG2B_HUMAN
NCBI Gene ID 441581
API
Download Associations
Predicted Functions View FRG2B's ARCHS4 Predicted Functions.
Co-expressed Genes View FRG2B's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View FRG2B's ARCHS4 Predicted Functions.

Functional Associations

FRG2B has 685 functional associations with biological entities spanning 7 categories (molecular profile, functional term, phrase or reference, disease, phenotype or trait, chemical, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 33 datasets.

Click the + buttons to view associations for FRG2B from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of FRG2B gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of FRG2B gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of FRG2B gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CM4AI KOLF21J CRISPRi Gene Perturbation Atlas gene perturbations changing expression of FRG2B gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing FRG2B protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with FRG2B protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with FRG2B protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of FRG2B gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with FRG2B gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by FRG2B gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with FRG2B gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with FRG2B gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of FRG2B gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of FRG2B gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GO Cellular Component Annotations 2015 cellular components containing FRG2B protein from the curated GO Cellular Component Annotations 2015 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of FRG2B gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of FRG2B gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
HPA Tissue Protein Expression Profiles tissues with high or low expression of FRG2B protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for FRG2B protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of FRG2B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of FRG2B gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of FRG2B gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of FRG2B gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain FRG2B protein from the LOCATE Predicted Protein Localization Annotations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of FRG2B gene from the NIBR DRUG-seq U2OS MoA Box dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of FRG2B gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at FRG2B gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
Rummagene Transcription Factor Associations 2026 transcription factors regulating expression of FRG2B gene from the Rummagene Transcription Factor Associations 2026 dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of FRG2B gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of FRG2B gene from the RummaGEO Gene Perturbation Signatures dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of FRG2B gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with FRG2B protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with FRG2B protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.